UK health minister confirms talks with AstraZeneca over new variant vaccines

UK is in talks with Oxford and AstraZeneca (AZN.L) for additional doses of their COVID-19 vaccine, which has been modified to better target the “beta” coronavirus variant first identified in South Africa, Health Secretary Matt Hancock said Wednesday.

“We have entered into commercial negotiations with AstraZeneca to secure a vaccine variant: future supplies of the Oxford AstraZeneca vaccine adapted to combat the B.1.351 variant first identified in South Africa,” Hancock said in a speech at the university Oxford. Continue reading

Our standards: The Thomson Reuters Trust Principles.

Comments are closed.